A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...

SAN ANTONIO, Texas, September 18, 2025--(BUSINESS WIRE)--NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity ...

LAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Abstracts presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas will spotlight a series of innovative research ...

* New urine biomarker test shows over 90% accuracy in detecting prostate cancer * Test works even when PSA levels appear normal * Biomarker levels drop after //surgery, confirming prostate origin ...

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

A know-how licensing agreement for a non-invasive electrochemical screening technology, based on research by Prof. A. L. Roy Vellaisamy, Chair Professor of Intelligent Systems in the School of Science ...

A new mobile prostate cancer screening bus will begin visiting neighborhoods this month, offering free screenings to raise awareness and promote early detection. The initiative, supported by the ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

Add Yahoo as a preferred source to see more of our stories on Google. The scan works by using a molecule that binds to prostate cancer cells, causing them to appear as bright spots on imaging A scan ...

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.